ReviewNeuropharmacology2019
Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphine.
Chloe J Jordan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
45 papers cite it
this paperpooled ittrialcites it